Clinical trials for endometrial cancer
WebEndometrial cancer is one of the most common gynecologic cancers. If it is caught at an early stage, it can be treated more easily. Women who have this type of cancer often have a history of irregular menstrual bleeding. They may also have abnormal findings during gynecologic exams. WebApr 6, 2016 · Interventional (Clinical Trial) Actual Enrollment : 78 participants: Allocation: Randomized: Intervention Model: Parallel Assignment: Intervention Model Description: randomized, double-blind, placebo-controlled ... Histological confirmed endometrial cancer of endometrioid type. Mixed tumor histology is allowed if the non-endometrioid …
Clinical trials for endometrial cancer
Did you know?
Web4 hours ago · Additionally, as a member of the POA, institutions have access to Caris CODEai™, the most comprehensive data solution in the industry with cancer treatment information and real-world clinical ... WebJun 11, 2024 · Participant has histologically or cytologically proven endometrial cancer with recurrent or advanced disease. Participant must have primary Stage III or Stage IV disease or first recurrent endometrial cancer with a low potential for cure by radiation therapy or surgery alone or in combination and meet at least one of the following criteria;
WebMay 20, 2024 · Signs and symptoms of endometrial cancer may include: Vaginal bleeding after menopause Bleeding between periods Pelvic pain When to see a doctor Make an appointment with your doctor if you experience any persistent signs or symptoms that worry you. From Mayo Clinic to your inbox Web4 hours ago · About half of patients had recurrent endometrial cancer (52.0%), and the other half had stage III or IV disease (48.0%). Most patients (85.3%) were still receiving treatment, which included...
WebApr 13, 2024 · AK104-207 is an open, multicenter, phase Ib/II clinical study, which aims to evaluate the effectiveness and safety of Cadonilimab combined with chemotherapy as the first-line treatment for locally advanced or metastatic non-small cell lung cancer that cannot be operated and cannot receive radical concurrent/sequential radiotherapy and … WebView Clinical Trials E ndometrial cancer is the most common cancer of the female reproductive organs. It starts in the endometrium, a layer of tissue that lines the interior of the uterus, or womb. The uterus is where a fetus grows when a woman is pregnant. It is hollow and pear shaped with two main parts:
WebApr 23, 2024 · US Clinical Trials Registry Clinical Trial Page Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer MARF-E- Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer This information was retrieved directly from the website clinicaltrials.gov without any changes.
WebEndometrial biopsy: This procedure uses a small, flexible tube that is put into the uterus to collect an endometrial tissue sample. The sample is examined under a microscope to see if cancer or other abnormal cells are present. An endometrial biopsy procedure is often done in a doctor’s office. shiny kilowatteralWebAug 13, 2024 · This clinical trial included 58 women with HER2-positive USC that had spread beyond the uterus or returned after treatment who had undergone a hysterectomy. They were assigned by chance to receive standard treatment with the chemotherapy drugs carboplatin and paclitaxel or the same treatment plus trastuzumab. shiny keyboard fixWebIn 2024, 417 thousand new cases of endometrial cancer were diagnosed, which accounted for 2.2% of all cancers . There were also nearly 97,000 deaths caused by this cancer—1.0% of all cancer-related deaths. A major risk factor for endometrial cancer is estrogen exposure . The role of CXCL1 in this cancer has been poorly studied; nevertheless ... shiny king anime adventuresWeb2 days ago · A northwest Louisiana hospital took part in groundbreaking research that could change how doctors treat endometrial cancer. On Monday, Willis-Knighton announced that its cancer center took part in research that has been shown to create meaningful improvements for the progression of survival for women who have primary advanced or … shiny kilowatrellWebMar 21, 2024 · Inclusion Criteria: Has Stage III, Stage IV, or recurrent, histologically-confirmed endometrial carcinoma with disease that is either measurable or nonmeasurable but radiographically apparent, per RECIST 1.1 as assessed by BICR (note: may have received prior chemotherapy only if administered concurrently with radiation; may have … shiny killer queen ybaWebSep 20, 2024 · Memorial Sloan Kettering Cancer Center, 8 New Jersey and New York locations. Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer. ClinicalTrials.gov Identifier: NCT02684227. M.D. Anderson Cancer Center, 6 locations in Texas. shiny keycapsWebApr 5, 2024 · The EORTC QLQ-C30 is a questionnaire that rates the overall quality of life in cancer participants. The first 28 questions use a 4-point scale (1=not at all to 4=very much) for evaluating function (physical, role, social, cognitive, emotional), symptoms (diarrhea, fatigue, dyspnea, appetite loss, insomnia, nausea/vomiting, constipation, and pain) and … shiny keyboard png